(Q40680486)

English

Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach

scientific article published on September 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

chronic myeloid leukemia

0 references

hydroxycarbamide

1 reference

based on heuristic

inferred from title

author name string

Jehn U

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Pötscher C

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Heinemann V

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 September 1995

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

153-157

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.

1 reference

https://api.crossref.org/works/10.3109%2F10428199509059670

21 January 2018

Treatment of terminal-phase chronic myelogenous leukemia with intermediate-dose cytarabine and hydroxyurea

1 reference

https://api.crossref.org/works/10.3109%2F10428199509059670

21 January 2018

Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside

1 reference

https://api.crossref.org/works/10.3109%2F10428199509059670

21 January 2018

Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.

1 reference

https://api.crossref.org/works/10.3109%2F10428199509059670

21 January 2018

Differentiation of blasts from patients in myeloid crisis of chronic myelogenous leukemia by in-vivo and in-vitro plicamycin treatment.

1 reference

https://api.crossref.org/works/10.3109%2F10428199509059670

21 January 2018

Blast crisis--reversing the direction.

1 reference

https://api.crossref.org/works/10.3109%2F10428199509059670

21 January 2018

Identifiers

10.3109/10428199509059670

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

release_mo6j7qxaqjh3pjveha4plzl6ri

1 reference

https://api.fatcat.wiki/v0/release/mo6j7qxaqjh3pjveha4plzl6ri

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40680486&oldid=1904509554"